Nothing Special   »   [go: up one dir, main page]

AU8547291A - Monoclonal antibodies against tenascin - Google Patents

Monoclonal antibodies against tenascin

Info

Publication number
AU8547291A
AU8547291A AU85472/91A AU8547291A AU8547291A AU 8547291 A AU8547291 A AU 8547291A AU 85472/91 A AU85472/91 A AU 85472/91A AU 8547291 A AU8547291 A AU 8547291A AU 8547291 A AU8547291 A AU 8547291A
Authority
AU
Australia
Prior art keywords
monoclonal antibodies
antibodies against
against tenascin
tenascin
monoclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU85472/91A
Inventor
Meenhard Herlyn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wistar Institute of Anatomy and Biology
Original Assignee
Wistar Institute of Anatomy and Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wistar Institute of Anatomy and Biology filed Critical Wistar Institute of Anatomy and Biology
Publication of AU8547291A publication Critical patent/AU8547291A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU85472/91A 1990-09-05 1991-09-05 Monoclonal antibodies against tenascin Abandoned AU8547291A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57773290A 1990-09-05 1990-09-05
US577732 2000-05-22

Publications (1)

Publication Number Publication Date
AU8547291A true AU8547291A (en) 1992-03-30

Family

ID=24309942

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85472/91A Abandoned AU8547291A (en) 1990-09-05 1991-09-05 Monoclonal antibodies against tenascin

Country Status (2)

Country Link
AU (1) AU8547291A (en)
WO (1) WO1992004464A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436132A (en) * 1993-02-13 1995-07-25 Amano Pharmaceutical Co., Ltd. Quantitative determination of tenascin as glioma marker
WO1996008513A1 (en) * 1994-09-16 1996-03-21 The Scripps Research Institute Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same
IT1307864B1 (en) * 1999-04-20 2001-11-19 Istituto Naz Per La Ricerca Su DIAGNOSTIC METHOD FOR THE RECOGNITION OF HUMAN NEOPLASIA THROUGH THE DETERMINATION OF THE CTN-C ISOFORM OF TN-C, FRAGMENTS OF
US20020187100A1 (en) * 2000-12-21 2002-12-12 David Rizzieri Anti-tenascin monoclonal antibody therapy for lymphoma
GB0207224D0 (en) 2002-03-27 2002-05-08 Novartis Forschungsstiftung Tenascin-W compositions and uses thereof

Also Published As

Publication number Publication date
WO1992004464A1 (en) 1992-03-19
WO1992004464A3 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
AU3811495A (en) Antibodies
AU4618193A (en) Humanized antibodies
AU5869596A (en) Anti-gp130 monoclonal antibodies
AU6080794A (en) Antibodies directed against binding-associated epitopes
AU7766391A (en) Thrombus-specific antibody derivatives
AU2645297A (en) Hepatitis b monoclonal antibodies
AU3330689A (en) Monoclonal antibodies
ZA898777B (en) Monoclonal antibodies
AU4450389A (en) Anti-fucosylcermiade monoclonal antibody
AU1423892A (en) Monoclonal antibodies directed towards mycobacterial antigens
EP0506523A3 (en) Monoclonal antibodies
AU6725190A (en) Anti-platelet monoclonal antibody
AU8547291A (en) Monoclonal antibodies against tenascin
AU6059194A (en) Monoclonal antibodies to bovine cytokines
ZA89258B (en) Monoclonal antibodies
AU7862291A (en) Modified antibodies
GB8927389D0 (en) Monoclonal antibodies
GB8820036D0 (en) Monoclonal antibodies
AU1809695A (en) Tumor associated monoclonal antibody 123av16
ZA912136B (en) Anti-oncostatin m monoclonal antibodies
AU612766C (en) Monoclonal antibodies
AU8490891A (en) Platelet fibrinogen-specific monoclonal antibody
AU2843989A (en) Monoclonal antibodies
IE900593L (en) Monoclonal antibodies